Biotech · Private company · Emeryville, CA, US
Gritstone bio, Inc.
SEC CIK 0001656634
Track this companyFree. Adds Gritstone bio, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials50 recruiting or active
Pipeline programs16From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline16
- Adjuvant chemotherapyPhase 2 · Colonic NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
- AtezolizumabPhase 2 · Colonic NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
- GRT-C901Phase 2 · Non Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- GRT-C901Phase 2 · Colonic NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
- GRT-C903Phase 2 · Non-Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- GRT-R902Phase 2 · Non Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- GRT-R902Phase 2 · Colonic NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
- GRT-R904Phase 2 · Non-Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- ipilimumabPhase 2 · Non Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- IpilimumabPhase 2 · Colonic NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
- nivolumabPhase 2 · Non Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- blood collection for research (circulating tumor DNA [ctDNA])Metastatic Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
- blood collection for research (HLA typing)Metastatic Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
- Blood collection for research (HLA typing)Non Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- blood collection for research (next generation sequencing [NGS])Metastatic Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
- Blood collection for research (next-generation sequencing [NGS])Non Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- Study of an Individualized Vaccine Targeting Neoantigens in Combination With Immune Checkpoint Blockade for Patients With Colon CancerPHASE2 · WITHDRAWN · started May 19, 2022ClinicalTrials.gov NCT05456165 · fetched Nov 12, 2026
- A Screening Study Targeting Tumor-specific AntigensCOMPLETED · started Dec 14, 2021ClinicalTrials.gov NCT05158621 · fetched Nov 12, 2026
- A Study of a Personalized Cancer Vaccine Targeting Shared NeoantigensPHASE1_PHASE2 · COMPLETED · started Jul 18, 2019ClinicalTrials.gov NCT03953235 · fetched Nov 12, 2026
- A Study of a Personalized Neoantigen Cancer VaccinePHASE1_PHASE2 · COMPLETED · started Feb 13, 2019ClinicalTrials.gov NCT03639714 · fetched Nov 12, 2026
- A Study of Personalized Neoantigen Cancer VaccinesCOMPLETED · started Jul 25, 2018ClinicalTrials.gov NCT03794128 · fetched Nov 12, 2026
SEC filings7
- 8-K · 8-KSEC EDGAR · filed Apr 4, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Feb 25, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Feb 14, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jan 3, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Dec 13, 2024 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Nov 29, 2024 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Nov 15, 2024 · fetched Nov 12, 2026